Sign in

You're signed outSign in or to get full access.

Claire Herkes

Executive Vice President, Conferences at GARTNERGARTNER
Executive

About Claire Herkes

Claire Herkes, age 50, is Executive Vice President, Conferences at Gartner, Inc., a role she has held since July 2020. She joined Gartner in 2005 and previously led conferences product management, operations, production, and emerging markets; prior roles include Senior Account Director at George P. Johnson and early conferences experience at The Yankee Group . Under her business line, Gartner’s Conferences delivered all-time high revenue of $583 million in 2024 (+15% FX-neutral), while company-wide Contract Value (CV) grew 8%; 2024 EBITDA and revenue outcomes used for executive incentives were $1,586 million and $6,331 million, respectively, and “Say-on-Pay” support was 92% .

Past Roles

OrganizationRoleYearsStrategic Impact
Gartner, Inc.EVP, ConferencesJul 2020–presentLeads global conferences; segment achieved record $583M revenue in 2024 (+15% FX-neutral) .
Gartner, Inc.Various conferences leadership roles2005–2020Product management, operations, production, emerging markets; internal progression .
George P. JohnsonSenior Account DirectorNot disclosedEvent and experience marketing expertise .
The Yankee GroupConferences (career start)Not disclosedTechnology research/consulting conferences foundation .

External Roles

No external board roles or public company directorships disclosed in the executive officer bio for Ms. Herkes .

Performance Compensation

Company-wide executive incentive program design and 2024 outcomes (applicable to executive officers):

  • Annual cash bonus metrics (FX-neutral): 50% EBITDA and 50% Revenue; 2024 results certified at EBITDA $1,586M (payout 196.7%) and Revenue $6,331M (payout 128.5%), resulting in an aggregate bonus factor of 162.6% for participants in the Executive Performance Bonus Plan .
  • Long-term incentives: PSUs (70% weight) measured on 1-year CV, and stock-settled SARs (30% weight) with 7-year term; both vest 25% per year over 4 years. 2024 PSU CV outcome: CV target $5,222M, actual $5,262M (7.8% YoY), payout 120.8% of target earned; earned PSUs then vest 25% annually over four years .
Metric (2024)WeightMinimumTargetMaximumActualPayout
EBITDA (FX-neutral)50%$973M$1,497M$1,591M$1,586M196.7%
Revenue (FX-neutral)50%$5,355M$6,274M$6,474M$6,331M128.5%
PSU Performance (2024)WeightMinimumTargetMaximumActual at 12/31/24Payout
Contract Value (CV, FX-neutral)100%$4,392M$5,222M$5,456M$5,262M120.8%

Best-practice features: performance-based compensation mix (94% CEO, 86% other NEOs at target), longer vesting (4 years), capped incentives (2x), clawback policy aligned to SEC/NYSE, no hedging/pledging, double-trigger CiC vesting (no single-trigger) .

Equity Ownership & Alignment

  • Stock ownership guidelines: CEO 6x base salary; other executive officers 3x base salary; if not in compliance, executives must hold 50% of net after-tax shares from all released awards until guidelines are met .
  • Hedging and pledging: Prohibited for all directors, executive officers, and employees per Insider Trading Policy .
  • Clawback: Company will recoup excess incentive-based compensation upon a required accounting restatement for prior three fiscal years, for current/former executive officers .
  • Beneficial ownership data: The proxy’s detailed table lists NEOs and directors; Ms. Herkes’ individual share holdings are not separately disclosed. The Company notes, to its knowledge, none of the listed holdings are pledged; NEOs were in compliance with ownership guidelines at year-end .

Employment Terms

Terms applicable to “other executive officers” (i.e., executives other than the CEO):

ScenarioCash SeveranceEquity TreatmentHealth/OtherNotes
Termination without cause (no CiC)12 months’ base salary; paid per payroll schedule Unvested equity forfeited (except death, disability, retirement) Up to 12 months COBRA reimbursement Separation agreement includes confidentiality, non-compete, non-solicit obligations .
Double-trigger: termination within 12 months after Change in Control12 months’ base salary All unvested outstanding equity vests in full; PSUs at target if performance undetermined; SARs/Options exercisable as to all covered shares for 12 months Up to 12 months COBRA reimbursement No vesting on CiC alone; requires qualifying termination .
Death/DisabilityImmediate 100% vesting of unvested awards SARs exercisable up to earlier of expiration or 1 year post-termination 2024 PSUs adjusted to certified performance factor .
Retirement (eligibility: age ≥55 and ≥10 years of service)No severance; continued vesting in full per award terms (conditions apply); 2024 awards prorated if retirement in grant year SARs exercisable up to expiration date At 12/31/24, only Messrs. Hall, Safian, Dawkins were retirement-eligible; others (including Ms. Herkes) were not .

Company Performance Context (2019–2024)

Metric20202021202220232024
Total Shareholder Return: $100 initial value104217218293314
Peer Group TSR: $100 initial value123129105141159
Net Income ($ millions)2677948088821,254
Company-Selected Measure (CV, $ millions)3,6054,2474,6604,8395,262

Say-on-Pay: 92% approval in 2024 .

Compensation benchmarking peer group (used for 2024 planning): Adobe, Akamai, Aon, Autodesk, Cadence, Equifax, Intuit, Moody’s, ServiceNow, Splunk, SS&C, Synopsys, Interpublic Group, Thomson Reuters, Verisk, VMware, Workday .

Investment Implications

  • Strong segment performance: Conferences delivered record revenue and double-digit growth in 2024, signaling effective execution in Ms. Herkes’ remit; CV growth and high TSR provide supportive company-wide context .
  • Alignment and risk controls: Executive incentives are heavily performance-based with multi-year vesting, stringent ownership/holding requirements, and a robust clawback; hedging/pledging is prohibited—reducing misalignment risk and insider selling pressure triggers .
  • Retention and CiC economics: For executive officers, severance is modest (12 months base), with double-trigger CiC vesting; given Ms. Herkes was not retirement-eligible at 12/31/24, equity continuity depends on ongoing service or qualifying events—monitor for potential off-cycle grants or role changes that could affect vesting and supply .
  • Data visibility caveat: Individual compensation and ownership details for Ms. Herkes are not disclosed in the proxy’s NEO tables; analysts should track future proxies and any Form 4 filings for insider purchasing/selling to refine views on alignment and near-term selling pressure .